Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 456

Results For "RAT"

8031 News Found

Advanced library amplification mix delivers superior NGS data quality
Digitisation | April 14, 2023

Advanced library amplification mix delivers superior NGS data quality

NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.


Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare
Healthcare | April 14, 2023

Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare

The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova


India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh
Policy | April 13, 2023

India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh

India's strategy against Covid was more effective than any other countries in the world


LifeSigns introduces ‘Continuum Care’ for Patients
Medical Device | April 13, 2023

LifeSigns introduces ‘Continuum Care’ for Patients

Enabling wireless monitoring In ambulances and homes


ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients
News | April 13, 2023

ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients

ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.


LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
News | April 12, 2023

LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes

Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes


Zydus receives final approval from USFDA for Tavaborole Topical Solution
Drug Approval | April 12, 2023

Zydus receives final approval from USFDA for Tavaborole Topical Solution

Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States


CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells
News | April 12, 2023

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells


Zydus receives final approval from the USFDA for Azithromycin Tablets
Drug Approval | April 11, 2023

Zydus receives final approval from the USFDA for Azithromycin Tablets

Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States